Bacterial infections are often the underlying cause of chronic lung inflammation, to further investigate the potential beneficial effects of SSAO/VAP-1 inhibition in lung inflammation, animals underwent a bacterial infection model. The gene discussed is AOC2; the disease is bacterial infectious disease.